• Gut Microbiota Absence Alters RPE/Choroid Transcriptome in A

  2026-06-24

  This study reveals that germ-free mice lacking gut microbiota display substantial transcriptomic changes in retinal pigment epithelium (RPE) and choroid tissues, implicating gut–retina interactions in age-related macular degeneration (AMD) pathogenesis. The findings highlight a novel gut–RPE/choroidal axis and suggest that microbiota may influence neovascular features of AMD.

• GPX3 Modulates Gemcitabine Sensitivity in Pancreatic Cancer

  2026-06-23

  This study demonstrates that glutathione peroxidase 3 (GPX3) acts as a tumor suppressor in pancreatic cancer by inhibiting the JNK/c-Jun signaling pathway, which in turn reduces cell proliferation, migration, invasion, and enhances chemosensitivity to gemcitabine. The findings provide mechanistic insight into overcoming chemoresistance in pancreatic cancer and suggest new avenues for precision therapy.

• Trilaurin (Glycerol Tridodecanoate): Advanced Protocols & Ap

  2026-06-23

  Trilaurin (glycerol tridodecanoate) stands out as a robust lipid excipient for cutting-edge drug delivery and biocatalytic workflows, thanks to its reproducibility and versatility. Explore how new research and validated protocols make Trilaurin indispensable for oral peptide delivery, nanoparticle formulation, and enzymatic synthesis.

• HyperFluor™ 488 Goat Anti-Mouse IgG: Precision in Metabolic

  2026-06-22

  Explore how HyperFluor 488 Goat Anti-Mouse IgG enables advanced metabolic pathway detection in cellular studies. This article uniquely bridges fluorescence antibody technology with insights from mitochondrial research, offering actionable guidance for high-sensitivity assay design.

• Angiotensin II Applications: Hypertension and Vascular Remod

  2026-06-22

  Unlock the full potential of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) for modeling hypertension mechanisms, vascular remodeling, and smooth muscle hypertrophy. This guide delivers protocol insights, troubleshooting strategies, and advanced applications drawn from cutting-edge literature and practical workflows.

• Neuroinflammatory Mechanisms of Trigeminal Allodynia via CGR

  2026-06-21

  Liao et al. elucidate a neuroinflammatory cascade underlying mechanical allodynia in trigeminal neuralgia, highlighting the CGRP/SP-Piezo2 axis and Ca2+-dependent signaling in peripheral sensitization. Their findings bridge mechanotransduction, neuropeptide signaling, and transcriptional regulation, offering new mechanistic insight and potential research targets for neuropathic pain.

• A-1331852: Advancing BCL-XL Inhibition in Translational Onco

  2026-06-20

  Explore the evolving role of A-1331852, a potent BCL-XL inhibitor, in overcoming chemotherapy-induced senescence and driving precision apoptosis assays. This thought-leadership article combines mechanistic insights with strategic guidance for translational researchers, benchmarking A-1331852 against established paradigms and offering actionable protocol recommendations for robust, reproducible data in cancer research.

• Forskolin: Adenylate Cyclase Activator for Advanced 3D Organ

  2026-06-19

  Forskolin, a potent adenylate cyclase activator, empowers high-efficiency pancreatic ductal organoid generation by precisely modulating cAMP pathways. This guide details experimental workflows, protocol enhancements, and troubleshooting tips to maximize Forskolin’s value in regenerative, endocrine, and disease-modeling research.

• (S)-(+)-Dimethindene maleate: Technical Guidance for M2 Anta

  2026-06-19

  (S)-(+)-Dimethindene maleate provides researchers with a selective M2 muscarinic receptor antagonist and H1 histamine blocker for precise pharmacological modulation in autonomic, cardiovascular, and respiratory research. It is not intended for diagnostic or therapeutic use, and requires strict attention to solubility and solution stability. This guide details best practices to maximize reproducibility and avoid common workflow pitfalls.

• Nebivolol Hydrochloride: Benchmarking β1-Adrenoceptor Antago

  2026-06-18

  Nebivolol hydrochloride stands out as an ultra-selective β1-adrenoceptor antagonist, enabling precise dissection of cardiac adrenergic signaling in translational and preclinical research. This article delivers actionable protocols, advanced troubleshooting, and key comparative insights to ensure rigorous, reproducible results in cardiovascular pharmacology and β1-adrenergic receptor signaling studies.

• Linoleic Acid (C18:2): Emerging Roles in Translational Contr

  2026-06-18

  Explore the unique signaling and translational functions of Linoleic Acid (C18:2) in oxidative stress, membrane dynamics, and metabolic adaptation. This deep-dive article uncovers new mechanistic insights and assay implications beyond conventional workflows.

• SD 169 (Indole-5-carboxamide): Mechanisms and Strategy in Tr

  2026-06-17

  This thought-leadership article provides an advanced synthesis of the mechanistic and translational landscape surrounding SD 169 (indole-5-carboxamide), a selective ATP-competitive inhibitor of p38α and p38β MAPKs. By integrating recent structural insights—including dual-action dephosphorylation dynamics—with best-practice protocols and strategic guidance, the article empowers translational researchers to harness SD 169 for high-impact studies in inflammation, type 1 diabetes, and neuroregeneration. It bridges cutting-edge mechanistic findings with actionable strategies, outlines differentiation versus standard product literature, and positions SD 169 as a uniquely versatile tool for next-generation disease modeling.

• AP20187: Chemical Inducer of Dimerization for Precision Cont

  2026-06-17

  AP20187 unlocks rapid, tunable control of protein interactions and gene expression, enabling sophisticated conditional gene therapy and metabolic research. Its high solubility, purity, and proven in vivo efficacy set a new standard for regulated cell signaling experimentation.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocol & QC Guide

  2026-06-16

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody addresses specificity and sensitivity challenges in immunoassays by providing reliable detection of rabbit primary antibodies. It is best used in workflows such as ELISA, Western blot, and IHC where robust signal amplification is required. This reagent is not designed for diagnostic or clinical applications and should be employed strictly for research use.

• Miltefosine: Protocols and Innovations in Leukopenia Researc

  2026-06-16

  Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) is redefining hematology research as both a PI3K/Akt pathway inhibitor and a Ras/MEK/ERK pathway activator. This guide delivers actionable protocols, troubleshooting advice, and applied insights for leveraging Miltefosine in neutrophil differentiation and leukopenia models.

438 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page